Movatterモバイル変換
[0]
ホーム
URL:
画像なし
夜間モード
EN
FR
Export
export
Export
PDF
Word (DOCX)
Cancel
Download
EN
FR
Trastuzumab
Essential medicine status
General description
Trastuzumab is a monoclonal antibody used in the treatment of human epidermal growth factor receptor 2 positive (HER2+) breast cancer.
INN
Trastuzumab
ATC codes
L01FD01
Medicine type
Biological agent
EML status history
First added in 2015 (
TRS 994
) for
Carcinoma of breast, specialised type
Wikipedia
Trastuzumab
DrugBank
Trastuzumab
Recommendations
Section
Targeted therapies
Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection
Indications
Carcinoma of breast, specialised type
[8]
ページ先頭
©2009-2025
Movatter.jp
